Discern Health Moderates Two Panels on Patient-Reported Measures in Oncology

June 2019

Theresa Schmidt, MA, PMP, CSPO

In May, Discern Health Director Theresa Schmidt moderated two panels that built on the discussion presented in the National Pharmaceutical Council (NPC) and Discern white paper, Improving Patient-reported Measures in Oncology.

The panels at the annual meetings of the Pharmacy Quality Alliance (PQA) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) discussed gaps in patient-reported measures (PRMs) in oncology and examined controversies on this topic from multiple perspectives. PRMs are tools, such as surveys, that capture patients’ voices related to their care. Patient-reported performance measures (PR-PMs) translate PRM responses into metrics that can be used to assess provider performance, compare entities, and measure changes over time.

Read summaries of the PQA and ISPOR conference presentations here.

For more information, please contact Theresa Schmidt at tschmidt@discernhealth.com.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO